Artiva Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 17.96 M | $174.17 M | 82.23% | 45.56% |
| VIKING GLOBAL INVESTORS LP | 08/14/2026 | 2.60 M | $25.26 M | 100.00% | 6.61% |
| BLACKSTONE INC. | 08/14/2026 | 2.40 M | $23.31 M | 100.00% | 6.10% |
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2026 | 2.35 M | $22.83 M | 0.00% | 5.97% |
| VR ADVISER, LLC | 08/14/2026 | 2.04 M | $19.82 M | 26.97% | 5.19% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 2.00 M | $19.37 M | 283.84% | 5.07% |
| CALIGAN PARTNERS LP | 08/14/2026 | 1.74 M | $16.84 M | 100.00% | 4.40% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 981.82 K | $9.52 M | 372.74% | 2.49% |
| SAMSARA BIOCAPITAL, LLC | 08/14/2026 | 954.86 K | $9.26 M | 100.00% | 2.42% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/11/2026 | 874.54 K | $8.48 M | 100.00% | 2.22% |
| PROPEL BIO MANAGEMENT, LLC | 08/13/2026 | 696.44 K | $6.76 M | 375.81% | 1.77% |
| BLACKROCK, INC. | 08/07/2026 | 694.73 K | $6.74 M | 225.57% | 1.76% |
| CITADEL ADVISORS LLC | 09/02/2026 | 609.38 K | $5.91 M | 3,739.80% | 1.55% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 525.00 K | $5.09 M | 100.00% | 1.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 353.85 K | $3.43 M | 247.95% | 0.90% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 314.38 K | $3.05 M | 100.00% | 0.80% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 300.00 K | $2.91 M | 100.00% | 0.76% |
| REVELATION CAPITAL MANAGEMENT, LLC | 08/14/2026 | 299.31 K | $2.90 M | 0.00% | 0.76% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 273.62 K | $2.65 M | 173.62% | 0.69% |
| ACUTA CAPITAL PARTNERS, LLC | 08/14/2026 | 260.42 K | $2.53 M | 100.00% | 0.66% |
| KVP CAPITAL ADVISORS, LP | 08/13/2026 | 200.00 K | $1.94 M | 100.00% | 0.51% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 194.11 K | $1.88 M | 0.00% | 0.49% |
| UBS GROUP AG | 08/13/2026 | 184.02 K | $1.78 M | 11,951.08% | 0.47% |
| SEVEN GRAND MANAGERS, LLC | 08/14/2026 | 175.00 K | $1.70 M | 100.00% | 0.44% |
| STATE STREET CORP | 09/22/2026 | 165.76 K | $1.61 M | 362.72% | 0.42% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 151.00 K | $1.46 M | 88.66% | 0.38% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 148.39 K | $1.44 M | 352.28% | 0.38% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 118.62 K | $1.15 M | 100.00% | 0.30% |
| SIMPLIFY ASSET MANAGEMENT INC. | 07/16/2026 | 101.36 K | $983.14 K | 336.31% | 0.26% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 85.00 K | $824.50 K | 142.86% | 0.22% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 78.58 K | $762.18 K | -31.70% | 0.20% |
| NORTHERN TRUST CORP | 08/13/2026 | 76.42 K | $741.30 K | 526.01% | 0.19% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 67.10 K | $650.88 K | 100.00% | 0.17% |
| QUADRATURE CAPITAL LTD | 08/07/2026 | 49.35 K | $478.65 K | 100.00% | 0.13% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 44.82 K | $434.71 K | 120.00% | 0.11% |
| XTX TOPCO LTD | 08/14/2026 | 42.51 K | $412.34 K | 109.71% | 0.11% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 31.11 K | $301.80 K | 100.00% | 0.08% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 25.00 K | $242.50 K | 0.00% | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 22.94 K | $221.00 K | 100.00% | 0.06% |
| ATOM INVESTORS LP | 08/14/2026 | 22.85 K | $221.68 K | 100.00% | 0.06% |
| BAILARD, INC. | 07/30/2026 | 20.70 K | $200.79 K | 0.00% | 0.05% |
| SPARK INVESTMENT MANAGEMENT LLC | 08/10/2026 | 16.50 K | $160.05 K | 100.00% | 0.04% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 15.78 K | $153.07 K | 37.64% | 0.04% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 14.86 K | $144.09 K | 100.00% | 0.04% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 13.98 K | $135.61 K | 100.00% | 0.04% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 11.98 K | $116.19 K | 100.00% | 0.03% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 11.90 K | $115.39 K | 100.00% | 0.03% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 11.90 K | $115.39 K | 100.00% | 0.03% |
| NEW YORK STATE COMMON RETIREMENT FUND | 07/29/2026 | 6.10 K | $59.17 K | 100.00% | 0.02% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 5.86 K | $56.85 K | 6.74% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Artiva Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 83 institutional investors and hedge funds held shares of Artiva Biotherapeutics Inc. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 17.96 M
VIKING GLOBAL INVESTORS LP: 2.6 M
Blackstone Inc.: 2.4 M
5AM Venture Management, LLC: 2.35 M
VR Adviser, LLC: 2.04 M
FRANKLIN RESOURCES INC: 2 M
102.47% of Artiva Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 40.65 M shares in the last 24 months. This purchase volume represents approximately $232.12 M in transactions.